Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles

Abstract Glaucoma is a major cause of blindness and is frequently associated with elevated intraocular pressure. The trabecular meshwork (TM), the tissue that primarily regulates intraocular pressure, is known to have reduced cellularity in glaucoma. Thus, stem cells, if properly delivered to the TM...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: E. J. Snider, K. P. Kubelick, K. Tweed, R. K. Kim, Y. Li, K. Gao, A. T. Read, S. Emelianov, C. R. Ethier
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2018
Materias:
R
Q
Acceso en línea:https://doaj.org/article/6647e12fda074f039ae079b15de63faa
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:6647e12fda074f039ae079b15de63faa
record_format dspace
spelling oai:doaj.org-article:6647e12fda074f039ae079b15de63faa2021-12-02T15:08:22ZImproving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles10.1038/s41598-018-30834-72045-2322https://doaj.org/article/6647e12fda074f039ae079b15de63faa2018-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-018-30834-7https://doaj.org/toc/2045-2322Abstract Glaucoma is a major cause of blindness and is frequently associated with elevated intraocular pressure. The trabecular meshwork (TM), the tissue that primarily regulates intraocular pressure, is known to have reduced cellularity in glaucoma. Thus, stem cells, if properly delivered to the TM, may offer a novel therapeutic option for intraocular pressure control in glaucoma patients. For this purpose, targeted delivery of stem cells to the TM is desired. Here, we used magnetic nanoparticles (Prussian blue nanocubes [PBNCs]) to label mesenchymal stem cells and to magnetically steer them to the TM following injection into the eye’s anterior chamber. PBNC-labeled stem cells showed increased delivery to the TM vs. unlabeled cells after only 15-minute exposure to a magnetic field. Further, PBNC-labeled mesenchymal stem cells could be delivered to the entire circumference of the TM, which was not possible without magnetic steering. PBNCs did not affect mesenchymal stem cell viability or multipotency. We conclude that this labeling approach allows for targeted, relatively high-efficiency delivery of stem cells to the TM in clinically translatable time-scales, which are necessary steps towards regenerative medicine therapies for control of ocular hypertension in glaucoma patients.E. J. SniderK. P. KubelickK. TweedR. K. KimY. LiK. GaoA. T. ReadS. EmelianovC. R. EthierNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 8, Iss 1, Pp 1-13 (2018)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
E. J. Snider
K. P. Kubelick
K. Tweed
R. K. Kim
Y. Li
K. Gao
A. T. Read
S. Emelianov
C. R. Ethier
Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles
description Abstract Glaucoma is a major cause of blindness and is frequently associated with elevated intraocular pressure. The trabecular meshwork (TM), the tissue that primarily regulates intraocular pressure, is known to have reduced cellularity in glaucoma. Thus, stem cells, if properly delivered to the TM, may offer a novel therapeutic option for intraocular pressure control in glaucoma patients. For this purpose, targeted delivery of stem cells to the TM is desired. Here, we used magnetic nanoparticles (Prussian blue nanocubes [PBNCs]) to label mesenchymal stem cells and to magnetically steer them to the TM following injection into the eye’s anterior chamber. PBNC-labeled stem cells showed increased delivery to the TM vs. unlabeled cells after only 15-minute exposure to a magnetic field. Further, PBNC-labeled mesenchymal stem cells could be delivered to the entire circumference of the TM, which was not possible without magnetic steering. PBNCs did not affect mesenchymal stem cell viability or multipotency. We conclude that this labeling approach allows for targeted, relatively high-efficiency delivery of stem cells to the TM in clinically translatable time-scales, which are necessary steps towards regenerative medicine therapies for control of ocular hypertension in glaucoma patients.
format article
author E. J. Snider
K. P. Kubelick
K. Tweed
R. K. Kim
Y. Li
K. Gao
A. T. Read
S. Emelianov
C. R. Ethier
author_facet E. J. Snider
K. P. Kubelick
K. Tweed
R. K. Kim
Y. Li
K. Gao
A. T. Read
S. Emelianov
C. R. Ethier
author_sort E. J. Snider
title Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles
title_short Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles
title_full Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles
title_fullStr Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles
title_full_unstemmed Improving Stem Cell Delivery to the Trabecular Meshwork Using Magnetic Nanoparticles
title_sort improving stem cell delivery to the trabecular meshwork using magnetic nanoparticles
publisher Nature Portfolio
publishDate 2018
url https://doaj.org/article/6647e12fda074f039ae079b15de63faa
work_keys_str_mv AT ejsnider improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
AT kpkubelick improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
AT ktweed improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
AT rkkim improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
AT yli improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
AT kgao improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
AT atread improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
AT semelianov improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
AT crethier improvingstemcelldeliverytothetrabecularmeshworkusingmagneticnanoparticles
_version_ 1718388189232627712